Brief reportsSafety of intravitreal high-dose reinjections of triamcinolone acetonide
References (5)
- et al.
Intravitreal triamcinolone for refractory diabetic macular oedema
Ophthalmology
(2002) - et al.
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degenerationone-year results
Arch Ophthalmol
(2003)
There are more references available in the full text version of this article.
Cited by (61)
Combination Therapy with Intravitreal Triamcinolone Acetonide and Oral Levodopa for the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy: A Pilot Study
2022, Journal of Ocular Pharmacology and TherapeuticsTopical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study
2020, Journal of Ocular Pharmacology and TherapeuticsCombined low dose bevacizumab-triamcinolone versus bevacizumab single intravitreal injection for branch retinal vein occlusion
2018, Journal of Korean Ophthalmological Society
Copyright © 2004 Elsevier Inc. All rights reserved.